Federal Register Notice: FDA has determined that Demadex (torsemide) injection, 20 mg/2 mL (10 mg/mL) and 50 mg/5 mL (10 mg/mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow the agency to approve ANDAs for torsemide injection if all other legal and regulatory requirements are met. To view this notice, click here.
